These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 2775445)

  • 21. Structure-based design of lipophilic quinazoline inhibitors of thymidylate synthase.
    Jones TR; Varney MD; Webber SE; Lewis KK; Marzoni GP; Palmer CL; Kathardekar V; Welsh KM; Webber S; Matthews DA; Appelt K; Smith WW; Janson CA; Villafranca JE; Bacquet RJ; Howland EF; Booth CL; Herrmann SM; Ward RW; White J; Moomaw EW; Bartlett CA; Morse CA
    J Med Chem; 1996 Feb; 39(4):904-17. PubMed ID: 8632414
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis and calcium channel antagonist activity of alkyl cycloalkyl esters of nifedipine containing pyridinyl substituents.
    Akula MR; Matowe WC; Wolowyk MW; Knaus EE
    Drug Des Deliv; 1989 Dec; 5(2):117-23. PubMed ID: 2577981
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis and in vitro antitumor activity of novel series 2-benzylthio-4-chlorobenzenesulfonamide derivatives.
    Sławiński J; Brzozowski Z
    Eur J Med Chem; 2006 Oct; 41(10):1180-9. PubMed ID: 16777268
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Charge densities of atoms of conjugated styryl ketones having activity against L1210 leukemia cells.
    Dimmock JR; Erciyas E; Sidhu KK; Luo X; Mezey PG; Allen TM; Murray L
    Drug Des Deliv; 1990 Dec; 7(1):45-9. PubMed ID: 2096833
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis, structural characterization, and in vitro antitumor activity of novel N-(6-chloro-1,1-dioxo-1,4,2-benzodithiazin-3-yl)arylsulfonamides.
    Brzozowski Z; Saczewski F; Sławiński J; Bednarski PJ; Grünert R; Gdaniec M
    Bioorg Med Chem; 2007 Apr; 15(7):2560-72. PubMed ID: 17306551
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cytotoxic activities of Mannich bases of chalcones and related compounds.
    Dimmock JR; Kandepu NM; Hetherington M; Quail JW; Pugazhenthi U; Sudom AM; Chamankhah M; Rose P; Pass E; Allen TM; Halleran S; Szydlowski J; Mutus B; Tannous M; Manavathu EK; Myers TG; De Clercq E; Balzarini J
    J Med Chem; 1998 Mar; 41(7):1014-26. PubMed ID: 9544201
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Asymmetrically substituted ethylenediamine platinum(II) complexes as antitumor agents: synthesis and structure-activity relationships.
    Mailliet P; Segal-Bendirdjian E; Kozelka J; Barreau M; Baudoin B; Bissery MC; Gontier S; Laoui A; Lavelle F; Le Pecq JB
    Anticancer Drug Des; 1995 Jan; 10(1):51-73. PubMed ID: 7695813
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis of 1-O-alkyl-2-O-methyl-glycerophospholipids with potential antitumor activity.
    Alunni-Bistocchi G; Orvietani PL; Ricci A; Binaglia L; Orlando M; Orlando P
    Farmaco; 1990 May; 45(5):499-509. PubMed ID: 2222722
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Carbonic anhydrase inhibitors. Synthesis of water-soluble, topically effective, intraocular pressure-lowering aromatic/heterocyclic sulfonamides containing cationic or anionic moieties: is the tail more important than the ring?
    Scozzafava A; Menabuoni L; Mincione F; Briganti F; Mincione G; Supuran CT
    J Med Chem; 1999 Jul; 42(14):2641-50. PubMed ID: 10411484
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis and antiviral and cytotoxic activity of iodohydrin and iodomethoxy derivatives of 5-vinyl-2'-deoxyuridines, 2'-fluoro-2'-deoxyuridine, and uridine.
    Kumar R; Xu LH; Knaus EE; Wiebe LI; Tovell DR; Tyrrell DL; Allen TM
    J Med Chem; 1990 Feb; 33(2):717-23. PubMed ID: 2299637
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vitro and in vivo activity of 1-aryl-3-(2-chloroethyl) urea derivatives as new antineoplastic agents.
    Lacroix J; Gaudreault RC; Pagé M; Joly LP
    Anticancer Res; 1988; 8(4):595-8. PubMed ID: 3052247
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Merocyanines: potential new anticancer agents.
    Gruda I; Pagé M; Bolduc F; Laliberté S; Noel C
    Anticancer Res; 1987; 7(6):1124-7. PubMed ID: 3442410
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 1-Amino-substituted 8-hydroxy-4,5-dimethyl-5H-pyrido[4,3-b]indoles with propyl- or methyl substituents at the 9-, and 7,9-positions: synthesis and biological evaluation.
    Costache E; Nguyen CH; Léonce S; Pierré A; Atassi G; Bisagni E
    Anticancer Drug Des; 1998 Jun; 13(4):361-72. PubMed ID: 9627673
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthesis and antiinflammatory activity of 5-(1,6-dihydropyridyl)-tetrazol-2-acetic acids, esters and amides.
    Kumar P; Knaus EE
    Drug Des Discov; 1994 Jan; 11(1):15-22. PubMed ID: 8068816
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthesis and antitumor activity of N-sulfonyl derivatives of nucleobases and sulfonamido nucleoside derivatives.
    Zinić B; Krizmanić I; Glavas-Obrovac Lj; Karner I; Zinić M
    Nucleosides Nucleotides Nucleic Acids; 2003; 22(5-8):1623-5. PubMed ID: 14565481
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Design, synthesis and anticancer evaluation of novel tetrahydroquinoline derivatives containing sulfonamide moiety.
    Ghorab MM; Ragab FA; Hamed MM
    Eur J Med Chem; 2009 Oct; 44(10):4211-7. PubMed ID: 19540022
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis of new coumarin 3-(N-aryl) sulfonamides and their anticancer activity.
    Reddy NS; Mallireddigari MR; Cosenza S; Gumireddy K; Bell SC; Reddy EP; Reddy MV
    Bioorg Med Chem Lett; 2004 Aug; 14(15):4093-7. PubMed ID: 15225733
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 1,4-disubstituted anthracene antitumor agents.
    Iyengar BS; Dorr RT; Alberts DS; Sólyom AM; Krutzsch M; Remers WA
    J Med Chem; 1997 Nov; 40(23):3734-8. PubMed ID: 9371238
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Acyl sulfonamide anti-proliferatives: benzene substituent structure-activity relationships for a novel class of antitumor agents.
    Lobb KL; Hipskind PA; Aikins JA; Alvarez E; Cheung YY; Considine EL; De Dios A; Durst GL; Ferritto R; Grossman CS; Giera DD; Hollister BA; Huang Z; Iversen PW; Law KL; Li T; Lin HS; Lopez B; Lopez JE; Cabrejas LM; McCann DJ; Molero V; Reilly JE; Richett ME; Shih C; Teicher B; Wikel JH; White WT; Mader MM
    J Med Chem; 2004 Oct; 47(22):5367-80. PubMed ID: 15481975
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis and in vitro anti-tumor activity of N-{1-[(3-thioxo-5,6-dihydroimidazo[2,1-c][1,2,4]thiadiazol-7-ylthio)thiocarbonyl]-2-imidazolidene}arylsulfonamides.
    Saczewski J; Brzozowski Z; Saczewski F; Bednarski PJ; Liebeke M; Gdaniec M
    Bioorg Med Chem Lett; 2006 Jul; 16(14):3663-7. PubMed ID: 16682194
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.